Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing DRGs: knowing what to cut--and when.

J Keefe, P Dubé, W Jollie

    Radiology Management
    |August 9, 1983
    PubMed
    Summary

    Medicare

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Combination Therapies in Drug Repurposing: Personalized Approaches to Combatting Leukaemia and Multiple Myeloma.

    Advances in experimental medicine and biology·2025
    Same author

    The first-in-Africa ex vivo drug sensitivity testing platform identifies novel drug combinations for South African leukaemia patient cohort.

    Scientific reports·2025
    Same author

    Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Society, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, London, Ont. Sept. 15-18, 2011.

    Canadian journal of surgery. Journal canadien de chirurgie·2022
    Same author

    Canadian Surgery Forum.

    Canadian journal of surgery. Journal canadien de chirurgie·2022
    Same author

    2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021.

    Canadian journal of surgery. Journal canadien de chirurgie·2022
    Same author

    Canadian guidelines on the management of colorectal peritoneal metastases.

    Current oncology (Toronto, Ont.)·2020

    Area of Science:

    • Health economics
    • Hospital administration
    • Radiology management

    Background:

    • Medicare is transitioning from retrospective, cost-based reimbursement to a prospective Diagnosis-Related Group (DRG) system.
    • This shift presents a fundamental conflict with existing financial incentives for hospitals.

    Purpose of the Study:

    • To highlight the managerial challenges posed by Medicare's DRG reimbursement system during its phase-in period.
    • To inform hospital administrators, particularly in radiology, about the dual reimbursement methodologies and associated cost-cutting imperatives.

    Main Methods:

    • Analysis of the conflicting incentives between retrospective cost-based and prospective DRG reimbursement models.
    • Examination of the implications of a three-year phase-in period where both systems are active.

    Main Results:

    • The phase-in period creates a unique managerial challenge, requiring administrators to navigate dual reimbursement systems.
    • Hospital administrators must strategically plan cost reductions applicable to both retrospective and prospective payment models.

    Conclusions:

    • Effective management during the Medicare DRG phase-in requires a dual focus on cost control under both old and new systems.
    • Radiology and hospital administrators need to understand the timing and scope of cost-cutting measures for successful adaptation to DRG reimbursement.

    Related Experiment Videos